COLIMYCIN
ESPID Education. Cohen R. May 6, 2010; 4844
Dr. Robert Cohen
Dr. Robert Cohen

This content is available to ESPID members only


Click here for more information or if you are considering becoming an ESPID member.

Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
After viewing this presentation the participant will be able to:

- Review the mechanism of action, pharmacokinetic/dynamic properties of colistin
- Discuss the advantages and disadvantages of colistin for the treatment of bacterial infections resistant to antibiotics in pediatrics
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies